Rat Intrastriatal Neural Allografts Challenged with Skin Allografts at Different Time Points

Experimental Neurology

Volumn 148, Issue 1, 1997, Pages 334-347

  Duan, Wei Ming ^a   Cameron, Reynolds Michael ^a   Brundin, Patrik ^a   Widner, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTOCOMPATIBILITY ANTIGEN; HISTOCOMPATIBILITY ANTIGENS RT, RAT; NERVE PROTEIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; ASTROCYTE; BRAIN TRANSPLANTATION; CELL COUNT; CHEMISTRY; CORPUS STRIATUM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT REJECTION; IMMUNIZATION; IMMUNOLOGY; LEWIS RAT; LOCOMOTION; MESENCEPHALON; NERVE CELL; PATHOLOGY; POSTOPERATIVE PERIOD; PRENATAL DEVELOPMENT; RAT; SKIN TRANSPLANTATION; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

AMPHETAMINE; ANIMALS; ASTROCYTES; BRAIN TISSUE TRANSPLANTATION; CELL COUNT; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS; IMMUNIZATION; LOCOMOTION; MESENCEPHALON; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; POSTOPERATIVE PERIOD; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 0031264159     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6656     Document Type: Article

References (33)

1. Abercrombie, M. 1946. Estimation of nuclear population from microtome sections. Anat. Rec. 94: 239-247.
2. Broadwell, R. D., H. M. Charlton, B. J. Balin, and M. Salcman. 1987. Angioarchitecture of the CNS, pituitary gland and intracerebral grafts revealed with peroxidase cytochemistry. J. Comp. Neurol. 260: 47-62.
3. Brundin, P., G. Barbin, R. E. Strecker, O. Isacson, A. Prochiantz, and A. Björklund. 1988. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39: 233-243.
4. Brundin, P., H. Widner, O. G. Nilsson, R. E. Strecker, and A. Björklund. 1989. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Expl. Brain Res. 75: 195-207.
5. 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalitis. Lab. Invest. 63: 162-170.
6. Defer, G. L., C. Geny, F. Ricolfi, G. Fenelon, J. C. Monfort, et al. 1996. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119: 41-50.
7. Duan, W. M., P. Brundin, and H. Widner. 1997. Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts. Neuroscience 77: 599-609.
8. Duan, W.-M., H. Widner, and P. Brundin. 1993. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: Will the second graft be rejected? Neuroscience 57: 261-274.
9. Duan, W.-M., H. Widner, and P. Brundin. 1995. Temporal pattern of expression of major histocompatibility complex antigens on intrastriatal grafts of syngeneic, allogeneic and xenogeneic neuronal tissue. Exp. Brain Res. 104: 227-242.
10. Duan, W M., H. Widner, E. M. Frodl, and P. Brundin. 1995. Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience 64: 629-641.
11. Freed, W. J. 1983. Functional brain tissue transplantation: Reversal of lesion-induced rotation by intraventricular substantial nigra and adrenal medulla grafts, with a note on intracranial retinal grafts. Biol. Psychiat. 18: 1205-1267.
12. Freed, W J., J. Dymecki, M. Poltorak, and C. R. Rodgers. 1988. Intraventricular brain allografts and xenografts: Studies of survival and rejection with and without systemic sensitization. In Progress in Brain Research (D. M. Gash and J. R. Sladek, Jr., Eds.), Vol. 78, pp. 103-137. Elsevier, Amsterdam.
13. Head, J. R., and W S. Griffin. 1985. Functional capacity of solid tissue transplants in the brain: Evidence for immunological privilege. Proc. R. Soc. London. (Biol.) 224: 375-387.
14. Hickey, W. F., B. L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-260.
15. Kordower, J. H., T. B. Freeman, B. J. Snow, F. J. Vingerhoets, E. J. Mufson et al. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124.
16. Kordower, J. H., J. M. Rosenstein, T. J. Collier, M. A. Burke, E.-Y. Chen, et al. 1996. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370: 203-230.
17. Krum, J. M., and J. F. Rosenstein. 1988. Patterns of angiogenesis in neural transplant models. II. Fetal neocortical transplants. J. Comp. Neurol. 271: 231-245.
18. Lawrence, J. M., R. J. Morris, D. J. Wilson, and G. Raisman. 1990. Mechanisms of allograft rejection in the rat brain. Neuroscience 37: 431-462.
19. Lindvall, O. 1994. Neural transplantation in Parkinson's disease. In Functional Neural Transplantation (S. B. Dunnett and A. Björklund, Eds.), pp. 103-137, Raven Press, New York.
20. Lindvall, O., P. Brundin, H. Widner, S. Rehncrona, B. Gustavii et al. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247: 574-577.
21. Mason, D. W., H. M. Charlton, A. J. Jones, C. B. Lavy, M. Puklavec, and S. J. Simmonds. 1986. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents. Neuroscience 19: 685-694.
22. Nicholas, M. K., J. P. Antel, K. Stefansson, and B. G. W. Arnason. 1987. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J. Immunol. 139: 2275-2283.
23. Olanow, C. W., J. H. Kordower, and T. B. Freeman. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19: 102-109.
24. Pakzaban, P., and O. Isacson. 1994. Neural xenotransplantation: Reconstruction of neural circuitry across species barriers. Neuroscience 62: 989-1001.
25. Poltorak, M., and W. J. Freed. 1991. BN rats do not reject F344 brain allografts even after systemic sensitization. Ann. Neurol. 29: 377-388.
26. Rao, K., R. D. Lund, H. W. Kunz, and T. J. Gill III. 1989. The role of MHC and non-MHC antigens in the rejection of intracerebral allogeneic neural grafts. Transplantation 48: 1018-1021.
27. Sauer, H., and P. Brundin. 1991. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Rest. Neurol. Neurosci. 2: 123-135.
28. Shinoda, M., J. L. Hudson, I. Strömberg, B. J. Hoffer, W. J. Moorhead, and L. Olson. 1995. Allogeneic grafts of fetal dopamine neurons: Immunological reactions following active and adoptive immunizations. Brain Res. 680: 180-195.
29. Ungerstedt, U., and G. W. Arbuthnott. 1970. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493.
30. Wekerle, H., C. Linington, H. Lassman, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trend. Neurosci. 9: 271-277.
31. Widner, H., and P. Brundin. 1993. Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplant. 2: 307-317.
32. Widner, H., P. Brundin, A. Björklund, and E. Möller. 1989. Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice. Exp. Brain Res. 76: 187-197.
33. Widner, H., J. Tetrud, S. Rehncrona, B. Snow, P. Brundin et al. 1992. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327: 1556-1563.